Stockscreener 앱 받기
91.26
1.02%
0.92
전일 마감가:
$90.34
열려 있는:
$90.61
하루 거래량:
1.33M
Relative Volume:
5.05
시가총액:
$907.13M
수익:
-
순이익/손실:
-
주가수익비율:
-
EPS:
-
순현금흐름:
-
1주 성능:
+3.83%
1개월 성능:
+5.78%
6개월 성능:
-6.34%
1년 성능:
+2.54%
1일 변동 폭
$90.51
$91.48
1주일 범위
$88.46
$91.48
52주 변동 폭
$84.48
$99.51
Vaneck Pharmaceutical Etf Stock (PPH) Company Profile
PPH을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
PPH
Vaneck Pharmaceutical Etf
|
91.26 | 907.13M | 0 | 0 | 0 | 0.00 |
|
VTI
Vanguard Total Stock Market Etf
|
295.92 | 417.53B | 0 | 0 | 0 | 0.00 |
|
SPY
Spdr S P 500 Etf Trust
|
599.94 | 372.57B | 0 | 0 | 0 | 0.00 |
|
IVV
Ishares Core S P 500 Etf
|
602.87 | 253.41B | 0 | 0 | 0 | 0.00 |
|
VB
Vanguard Small Cap Etf
|
239.61 | 160.59B | 0 | 0 | 0 | 0.00 |
|
QQQ
Invesco Qqq Trust Series 1
|
526.08 | 124.43B | 0 | 0 | 0 | 0.00 |
Vaneck Pharmaceutical Etf 주식(PPH)의 최신 뉴스
Should You Invest in the Invesco Pharmaceuticals ETF (PJP)? - MSN
Cencora Stock Outlook: Is Wall Street Bullish or Bearish? - TradingView
DeepSeek’s Disruption: The Impact on Nvidia and the Semiconductor Industry - VanEck
How to profit from AI innovation in 2025 - Equities News
Is Wall Street Bullish or Bearish on AbbVie Stock? - Inkl
The Investment Case for Bitcoin - VanEck
2025 Semiconductor Outlook: Investor Roadmap - VanEck
JPMorgan Chase & Co. Has $907,000 Stake in VanEck Pharmaceutical ETF (NASDAQ:PPH) - Defense World
Barclays PLC Sells 3,263 Shares of VanEck Pharmaceutical ETF (NASDAQ:PPH) - Defense World
Is Invesco Pharmaceuticals ETF (PJP) a Strong ETF Right Now? - MSN
Is Investing in the WisdomTree Cloud Computing ETF (WCLD) a Smart Move - espeaks.co.uk
Gold in 2024: Central Bank Demand, Rising Prices and the Equity Disconnect - VanEck
Eli Lilly Cuts Q4 Sales Forecast: ETFs to Buy on the Dip - MSN
Is Investing in the Invesco Semiconductors ETF (PSI) a Smart Move - espeaks.co.uk
What Trump's Presidency Will Mean for Bitcoin - VanEck
Tech Investing in 2025: Emerging Trends and Market Opportunities - VanEck
Should You Invest in the VanEck Pharmaceutical ETF (PPH)? - Yahoo Canada Finance
Annual ETF Highlights: A Dive Into the Best and Worst of 2024 - VanEck
Eli Lilly Cuts Q4 Sales Forecast: ETFs To Buy On The Dip - Barchart
Top 5 Cancer Pharma Stocks With Strong Risk/Reward In 2025 - Seeking Alpha
Taking a Look Under the Hood of VanEck’s Video Gaming and Esports Strategy - VanEck
The New Era of Defense: Global Trends and Investment Opportunities - VanEck
Sanctuary Advisors LLC Sells 41,736 Shares of VanEck Pharmaceutical ETF (NASDAQ:PPH) - Defense World
VanEck Pharmaceutical ETF (NASDAQ:PPH) Shares Acquired by Jane Street Group LLC - Defense World
Stifel Financial Corp Has $742,000 Holdings in VanEck Pharmaceutical ETF (NASDAQ:PPH) - Defense World
MML Investors Services LLC Decreases Position in Five Below, Inc. (NASDAQ:FIVE) - Defense World
MML Investors Services LLC Has $362,000 Position in VanEck Pharmaceutical ETF (NASDAQ:PPH) - Defense World
VanEck Mortgage REIT Income ETF (NYSEARCA:MORT) Shares Sold by Stifel Financial Corp - Defense World
Should You Invest in the iShares U.S. Pharmaceuticals ETF (IHE)? - MSN
World Equal Weight ETF | TSWE - VanEck
Broad Market Gains Shape Moat Strategies for 2025 - VanEck
Fmr LLC Buys 212 Shares of VanEck Pharmaceutical ETF (NASDAQ:PPH) - Defense World
PPH Is a Pertinent Healthcare Idea for 2025 - ETF Trends
VanEck’s 10 Crypto Predictions for 2025 - VanEck
Three Forces Powering the Nuclear Energy Surge - VanEck
Bank of Montreal Can Grows Position in VanEck Pharmaceutical ETF (NASDAQ:PPH) - Defense World
The Inflation Reduction Act: A Green Catalyst - VanEck
Winners And Losers: Post-Election Options Analysis - Barchart
A Better Way to Equal Weight? - VanEck
Big Pharma earnings season in spotlight amid positive sentiment - MSN
VanEck Mid-November Bitcoin ChainCheck - VanEck
Investment Opportunities in SMRs: The Future of Nuclear Power - VanEck
Are Wall Street Analysts Predicting Cencora Stock Will Climb or Sink? - MSN
October Gold Rally and Key Earnings Insights - VanEck
Vaneck Pharmaceutical Etf (PPH) 재무 분석
Vaneck Pharmaceutical Etf (PPH)에 대한 금융 데이터가 없습니다. 더 많은 정보를 위해 다른 주식을 확인해보세요.
매출
순이익
현금흐름
주당 순 이익
1.15%
자본화:
|
볼륨(24시간):